Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01337544 | Haploidentical Stem Cell Transplantation and IL-15 NK Cell Infusion for Paediatric Refractory Solid Tumours(NK) | terminated | Phase 1 / Phase 2 | 6 | Hospital Infantil Universitario Niño Jesús, Madrid, SpainOTHER | 1 | Nov 11, 2013 | clinicaltrials |
| NCT00708006 | A Study of HGS1029 (AEG40826-2HCl) in Subjects With Advanced Solid Tumors | completed | Phase 1 | 66 | Human Genome Sciences Inc.INDUSTRY | 1 | Nov 7, 2013 |
| clinicaltrials |
| NCT00002482 | Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer | unknown | Phase 1 / Phase 2 | — | St. Vincent Medical Center - Los AngelesOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT01110486 | ABT-348 as Monotherapy or Combination With Carboplatin or Docetaxel to Treat Advanced Solid Tumors | completed | Phase 1 | 102 | AbbVie (prior sponsor, Abbott)INDUSTRY | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00689065 | Safety Study of CALAA-01 to Treat Solid Tumor Cancers | terminated | Phase 1 | 24 | Calando PharmaceuticalsINDUSTRY | 1 | Nov 1, 2013 | clinicaltrials |
| NCT00413283 | Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 63 | AmgenINDUSTRY | 8 | Oct 24, 2013 | clinicaltrials |
| NCT01110083 | First-in-Man, Dose-escalation Trial of c-Met Kinase Inhibitor EMD 1204831 in Subjects With Advanced Solid Tumors | terminated | Phase 1 | 38 | EMD SeronoINDUSTRY | 1 | Oct 22, 2013 | clinicaltrials |
| NCT00031681 | 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00075634 | Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma | completed | Phase 1 | 21 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00138177 | Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors | completed | Phase 1 | 54 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00293345 | 3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00929903 | Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment | completed | Phase 1 | 55 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT01951846 | To Determine the Maximum Tolerated Dose (MTD) of BIBF 1120 in Patients With Solid Tumours | completed | Phase 1 | 61 | Boehringer IngelheimINDUSTRY | 1 | Sep 27, 2013 | clinicaltrials |
| NCT01161836 | An Open-label Study Investigating the Disposition and QT/QTc Interval Effects of 400 mg [14C]-Iniparib(3.7 MBq, 100 µCi) | completed | Phase 1 | 7 | SanofiINDUSTRY | 1 | Sep 24, 2013 | clinicaltrials |
| NCT00006088 | Vinorelbine in Treating Patients With Metastatic or Advanced Solid Tumors | unknown | Phase 1 | — | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00023816 | Carbendazim in Treating Patients With Advanced Solid Tumors or Lymphoma | unknown | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 0 | Sep 20, 2013 | clinicaltrials |
| NCT00060151 | GW786034 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Case Comprehensive Cancer CenterOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00169312 | Internet-Based Nutrition Education Program in Preventing Cancer in Participants of Health Maintenance Organizations | unknown | N/A | 2,619 | Josephine Ford Cancer CenterOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00313573 | Telemedicine or Standard Care in Treating Patients With Depression and/or Pain Caused By Cancer | unknown | Phase 3 | 480 | Indiana UniversityOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00349024 | Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer | unknown | N/A | 50 | Children's Cancer and Leukaemia GroupOTHER | 2 | Sep 20, 2013 | clinicaltrials |
| NCT00498992 | Regenecare® Wound Gel in Treating Rash in Patients Receiving Cetuximab or Other Epidermal Growth Factor Receptor Inhibitor Therapy for Cancer | unknown | N/A | 20 | Ingalls Memorial HospitalOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT01159301 | Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia | terminated | Phase 1 | 44 | National Cancer Institute (NCI)NIH | 1 | Sep 19, 2013 | clinicaltrials |
| NCT00024310 | Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors | unknown | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00128570 | An Individualized Internet-Based Health Behavior Program or a Standard Internet-Based Health Behavior Program in Preventing Cancer and Improving Physical Activity and Nutrition in Participants Who Are Physically Inactive With a Higher Body Mass Index | completed | N/A | 300 | Virginia Polytechnic Institute and State UniversityOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00301158 | Promoting Physical Activity In After-School Programs for Urban Adolescents | unknown | N/A | 420 | Montclair State UniversityOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00301678 | Personalized Nutrition Education in Improving Eating Habits of Healthy Participants Who Eat an Unhealthy Diet | unknown | N/A | 2,520 | Brown UniversityOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00324597 | AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma | unknown | Phase 1 | 18 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00710632 | Screening to Predict Weight Loss in Patients With Cancer | unknown | N/A | 220 | Queen's Medical CenterOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00674947 | A Phase I Study of BIIB015 in Relapsed/Refractory Solid Tumors | completed | Phase 1 | 55 | BiogenINDUSTRY | 1 | Sep 16, 2013 | clinicaltrials |
| NCT01017198 | Effect of Food and Antacid on BIIB021 With Advanced Solid Tumors | completed | Phase 1 | 20 | BiogenINDUSTRY | 1 | Sep 16, 2013 | clinicaltrials |
| NCT00721669 | A Phase I Dose-Escalation Study of IMGN388 in Patients With Solid Tumors | completed | Phase 1 | 60 | ImmunoGen, Inc.INDUSTRY | 1 | Sep 13, 2013 | clinicaltrials |
| NCT00387504 | Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | completed | Phase 1 | 21 | California Cancer ConsortiumNETWORK | 1 | Sep 12, 2013 | clinicaltrials |
| NCT00002939 | Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer | completed | Phase 1 | 21 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00956254 | Fentanyl Sublingual Spray in Treating Opioid-tolerant Cancer Patients With or Without Oral Mucositis | completed | Phase 3 | 18 | INSYS Therapeutics IncINDUSTRY | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00387998 | Health Education in Improving the Understanding of Medical Information | completed | N/A | 555 | Dartmouth-Hitchcock Medical CenterOTHER | 0 | Aug 30, 2013 | clinicaltrials |
| NCT00727584 | Radiation Therapy in Treating Patients With Metastatic Spinal Cord Compression | completed | N/A | 100 | Cancer Research UKOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00978185 | Acupressure Wristbands or Standard Care in Controlling Nausea Caused by Chemotherapy | completed | Phase 3 | 699 | University of ManchesterOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00005881 | Quality of Life in Children Treated for Cancer | completed | — | 538 | Children's Oncology GroupNETWORK | 1 | Aug 23, 2013 | clinicaltrials |
| NCT00550199 | LBH589 and Gemcitabine in the Treatment of Solid Tumors | terminated | Phase 1 | 17 | SCRI Development Innovations, LLCOTHER | 1 | Aug 19, 2013 | clinicaltrials |
| NCT00793975 | Study of IMC-1121B in Patients With Tumors That Have Not Responded to Therapy | completed | Phase 1 | 37 | Eli Lilly and CompanyINDUSTRY | 1 | Aug 19, 2013 | clinicaltrials |
| NCT01212341 | Allogeneic Natural Killer (NK) Cell Therapy in Patients With Lymphoma or Solid Tumor(MG4101) | completed | Phase 1 | 18 | Seoul National University HospitalOTHER | 1 | Aug 19, 2013 | clinicaltrials |
| NCT00227786 | Primary Care Physicians' Use of Stop-Smoking Plans to Help Patients Who Are Smokers | completed | N/A | 344 | Kaiser PermanenteOTHER | 1 | Aug 16, 2013 | clinicaltrials |
| NCT00569036 | Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors | completed | Phase 1 | 63 | Bristol-Myers SquibbINDUSTRY | 1 | Aug 14, 2013 | clinicaltrials |
| NCT01437280 | GOAT; Phase I Open Label Study of CGTG-102, a GM-CSF Encoding Oncolytic Adenovirus, for Advanced Cancers(GOAT) | withdrawn | Phase 1 | 0 | Baylor College of MedicineOTHER | 0 | Aug 14, 2013 | clinicaltrials |
| NCT00445497 | Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia | unknown | Phase 3 | 400 | Clatterbridge Centre for OncologyOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00514345 | CYP3A5 Gene as a Risk Factor for Kidney Damage in Young Patients With Cancer Treated With Ifosfamide | unknown | — | 300 | Children's Cancer and Leukaemia GroupOTHER | 2 | Aug 12, 2013 | clinicaltrials |
| NCT00897871 | Evaluating the Side Effects and How Well Anticancer Drugs Work in Very Young Patients With Cancer | unknown | — | 60 | Children's Cancer and Leukaemia GroupOTHER | 2 | Aug 12, 2013 | clinicaltrials |
| NCT00900354 | Pharmacokinetics of Dactinomycin in Young Patients With Cancer | unknown | — | 50 | Children's Cancer and Leukaemia GroupOTHER | 2 | Aug 12, 2013 | clinicaltrials |
| NCT00020644 | Continuous Infusion Gemcitabine in Treating Patients With Advanced Metastatic Cancer | unknown | Phase 1 | — | Advocate Lutheran General HospitalOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00898794 | Effect of Bevacizumab and VEGF on Platelet Clustering in Patients Who Are Receiving Bevacizumab for Cancer | unknown | — | 20 | Kantonsspital GraubündenOTHER | 1 | Aug 7, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Nov 11, 2013source: clinicaltrials